Most lately, it has been discovered that conolidine and the above mentioned derivatives act about the atypical chemokine receptor three (ACKR3. Expressed in comparable areas as classical opioid receptors, it binds to a big range of endogenous opioids. Not like most opioid receptors, this receptor acts as a scavenger and will not activate a second m